全球糖尿病护理设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计糖尿病护理设备市场将从 2025 年的 389.6 亿美元成长到 2034 年的 856 亿美元，2026 年至 2034 年的复合年增长率为 9.14%。

随着全球糖尿病盛行率的不断上升，全球糖尿病护理设备市场正迅速成长。糖尿病照护设备包括血糖值监测系统、胰岛素输注装置和持续血糖监测技术，这些设备能够帮助患者有效管理病情。生活方式的改变和人口老化导致糖尿病患者人数显着增加，进而大幅提升了对先进监测和治疗设备的需求。

多种因素正在推动该市场的成长。人们对糖尿病管理和定期血糖值监测重要性的认识不断提高，促使患者采用最新的护理设备。穿戴式血糖监测仪和智慧胰岛素帮浦等技术进步正在提升患者的便利性和治疗效果。

随着数位医疗和医疗技术创新不断改善疾病管理，糖尿病护理设备市场预计将持续成长。与行动医疗应用程式和数据分析的整合，能够实现更精准的监测和个人化的治疗方案。此外，医疗保健领域投资的增加以及医疗设备可近性的提高，也将推动市场的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球糖尿病护理设备市场：依产品类型划分

• 市场分析、洞察与预测
• 血糖值测量装置
• 试纸
• 血糖仪
• 自测血糖仪
• 连续血糖监测设备
• 《采血针》
• 胰岛素输注装置

第五章 全球糖尿病护理设备市场：依设备类型划分

• 市场分析、洞察与预测
• 自我测量
• 诊断

第六章：全球糖尿病照护设备市场：依剂型划分

• 市场分析、洞察与预测
• 泵浦
• 笔
• 注射器
• 注射器
• 可重复使用的笔芯
• 免洗笔
• 喷射注射器

第七章 全球糖尿病护理设备市场：依通路划分

• 市场分析、洞察与预测
• 向医疗机构销售
• 医院
• 诊所

第八章 全球糖尿病护理设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第九章 全球糖尿病护理设备市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Dexcom Inc
  • B. Braun SE
  • PHC Holdings Corporation
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • LifeScan
  • Tandem Diabetes Care
  • DarioHealth Corp
  • Glooko Inc
  • WellDoc Inc
  • AgaMatrix

The Diabetes Care Devices Market size is expected to reach USD 85.60 Billion in 2034 from USD 38.96 Billion (2025) growing at a CAGR of 9.14% during 2026-2034.

The global diabetes care devices market has grown rapidly due to the rising prevalence of diabetes worldwide. Diabetes care devices include blood glucose monitoring systems, insulin delivery devices, and continuous glucose monitoring technologies that help patients manage their condition effectively. With lifestyle changes and aging populations contributing to increased diabetes cases, the demand for advanced monitoring and treatment devices has expanded significantly.

Several factors are driving the growth of this market. Increasing awareness about diabetes management and the importance of regular blood glucose monitoring has encouraged patients to adopt modern care devices. Technological advancements, such as wearable glucose monitors and smart insulin pumps, have improved patient convenience and treatment outcomes.

In the future, the diabetes care devices market is expected to continue expanding as innovations in digital health and medical technology improve disease management. Integration with mobile health applications and data analytics may allow better monitoring and personalized treatment plans. Additionally, rising healthcare investments and improved access to medical devices will likely support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Blood Glucose Monitoring Devices
• Testing Strips
• Blood Glucose Meters
• Self-Monitoring Blood Glucose Meters
• Continuous Blood Glucose Monitoring Devices
• Lancets
• Insulin Delivery Devices

By Device Type

• Self-Monitoring
• Diagnostic

By Delivery Type

• Pumps
• Pen
• Syringes
• Injectors
• Cartridges In Reusable Pens
• Disposable Pens
• Jet Injectors

By Distribution Channel

• Institutional Sales
• Hospitals
• Clinics

By End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Abbott, Medtronic, F HoffmannLa Roche Ltd, Sanofi, Dexcom Inc, B Braun SE, PHC Holdings Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, LifeScan, Tandem Diabetes Care, DarioHealth Corp, Glooko Inc, WellDoc Inc, AgaMatrix
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIABETES CARE DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Blood Glucose Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Blood Glucose Meters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Self-Monitoring Blood Glucose Meters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Continuous Blood Glucose Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Lancets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Insulin Delivery Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIABETES CARE DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Self-Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIABETES CARE DEVICES MARKET: BY DELIVERY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Delivery Type
• 6.2. Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cartridges In Reusable Pens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Disposable Pens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Jet Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIABETES CARE DEVICES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Institutional Sales Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DIABETES CARE DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DIABETES CARE DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Device Type
  • 9.2.3 By Delivery Type
  • 9.2.4 By Distribution Channel
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Device Type
  • 9.3.3 By Delivery Type
  • 9.3.4 By Distribution Channel
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Device Type
  • 9.4.3 By Delivery Type
  • 9.4.4 By Distribution Channel
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Device Type
  • 9.5.3 By Delivery Type
  • 9.5.4 By Distribution Channel
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Device Type
  • 9.6.3 By Delivery Type
  • 9.6.4 By Distribution Channel
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DIABETES CARE DEVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott
  • 11.2.2 Medtronic
  • 11.2.3 F. Hoffmann-La Roche Ltd
  • 11.2.4 Sanofi
  • 11.2.5 Dexcom Inc
  • 11.2.6 B. Braun SE
  • 11.2.7 PHC Holdings Corporation
  • 11.2.8 Insulet Corporation
  • 11.2.9 Ascensia Diabetes Care Holdings AG
  • 11.2.10 LifeScan
  • 11.2.11 Tandem Diabetes Care
  • 11.2.12 DarioHealth Corp
  • 11.2.13 Glooko Inc
  • 11.2.14 WellDoc Inc
  • 11.2.15 AgaMatrix